Abstract Coronavirus disease-2019 (COVID-19) is primarily a respiratory disease, however,
an increasing number of reports indicate that SARS-CoV-2 infection can also cause severe …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of
neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection …

Abstract Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease causing a
worldwide pandemic in the year of 2019. SARS‐CoV‐2 is an enveloped, positive-stranded …

Objective Attention, working memory and executive processing have been reported to be
consistently impaired in Neuro-Long coronavirus disease (COVID). On the hypothesis of …

COVID-19 and especially Long COVID are associated with severe CNS symptoms and may
place persons at risk to develop long-term cognitive impairments. Here, we show that two …

SARS-CoV-2-induced excessive inflammation in brain leads to damage of blood-brain
barrier, hypoxic-ischemic injury, and neuron degeneration. The production of inflammatory …

Microglial cells, the immune cells of the central nervous system, are key elements regulating
brain development and brain health. These cells are fully responsive to stressors …

COVID-19-associated coinfections increase the patient's risk of developing a severe form of
the disease and, consequently, the risk of death. The term “flurona” was proposed to …

Résumé Un profil individuel d'hypométabolisme glucidique a été rapporté, au repos en
imagerie TEP cérébrale au 18 F-FDG, chez les patients présentant un COVID long avec …

Post-Acute Sequelae of COVID-19 (PASC) encompasses persistent neurological symptoms,
including olfactory and autonomic dysfunction. Here, we report chronic neurological …